n-methylaspartate has been researched along with Allergic Encephalomyelitis in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bernal-Chico, A; Brown, JM; Cipriani, R; Cravatt, BF; Hsu, KL; Manterola, A; Mato, S; Matute, C; Moreno-Rodríguez, M; Pérez-Samartín, A; Rodríguez-Puertas, R; Ruiz, A | 1 |
| Elbrønd-Bek, H; Jørgensen, SH; Kelly, NM; Weidner, MS; Wellejus, A | 1 |
| Bernardi, G; Berretta, N; Centonze, D; Feligioni, M; Gentile, A; Mandolesi, G; Mango, D; Mercuri, NB; Mori, F; Musella, A; Nicoletti, F; Nisticò, R; Piccinin, S; Pignatelli, M | 1 |
| Ahmed, Z; Baker, D; Croxford, JL; Cuzner, ML; Giovannoni, G; Hankey, DJ; Jackson, SJ; Ledent, C; Petzold, A; Pocock, JM; Pryce, G; Thompson, AJ | 1 |
| Bolton, C; Paul, C | 1 |
1 review(s) available for n-methylaspartate and Allergic Encephalomyelitis
| Article | Year |
|---|---|
Glutamate receptors in neuroinflammatory demyelinating disease.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Demyelinating Diseases; Encephalomyelitis, Autoimmune, Experimental; Humans; Inflammation; Models, Biological; Models, Chemical; Multiple Sclerosis; N-Methylaspartate; Receptors, Glutamate; Receptors, Kainic Acid | 2006 |
4 other study(ies) available for n-methylaspartate and Allergic Encephalomyelitis
| Article | Year |
|---|---|
Re-examining the potential of targeting ABHD6 in multiple sclerosis: Efficacy of systemic and peripherally restricted inhibitors in experimental autoimmune encephalomyelitis.
Topics: Animals; Benzoates; Biphenyl Compounds; Brain; Calcium; Carbamates; Cells, Cultured; Encephalomyelitis, Autoimmune, Experimental; Female; Inflammation; Mice; Mitochondria; Molecular Targeted Therapy; Monoacylglycerol Lipases; N-Methylaspartate; Neural Conduction; Piperidines; Pyramidal Tracts; Receptor, Cannabinoid, CB1; Triazoles | 2018 |
4-iodophenyl isothiocyanate: a neuroprotective compound.
Topics: 1-Methyl-4-phenylpyridinium; Analysis of Variance; Animals; Cells, Cultured; Cerebral Cortex; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Embryo, Mammalian; Encephalomyelitis, Autoimmune, Experimental; Enzyme Inhibitors; Excitatory Amino Acid Agonists; Glucose; Glutamic Acid; Herbicides; Hypoxia; Iodobenzenes; Isothiocyanates; L-Lactate Dehydrogenase; Monoamine Oxidase; N-Methylaspartate; Neurites; Neuroglia; Neurons; Neuroprotective Agents; Peroxides; Protein Binding; Rats; Rats, Wistar | 2012 |
Inflammation subverts hippocampal synaptic plasticity in experimental multiple sclerosis.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; CA1 Region, Hippocampal; Cell Line; Encephalomyelitis, Autoimmune, Experimental; Female; GABAergic Neurons; Interleukin-1beta; Long-Term Potentiation; Mice; Multiple Sclerosis; N-Methylaspartate; Synapses; Synaptic Transmission | 2013 |
Cannabinoids inhibit neurodegeneration in models of multiple sclerosis.
Topics: Animals; Aspartic Acid; Axons; Benzoxazines; Cannabinoids; Cyclohexanols; Dizocilpine Maleate; Encephalomyelitis, Autoimmune, Experimental; Excitatory Amino Acid Agonists; Gene Deletion; Humans; Mice; Mice, Transgenic; Monomeric GTP-Binding Proteins; Morpholines; Multiple Sclerosis; N-Methylaspartate; Naphthalenes; Nerve Degeneration; Nuclear Proteins; Receptors, Cannabinoid; Receptors, Drug; Receptors, N-Methyl-D-Aspartate; Retina; Saccharomyces cerevisiae Proteins; Spinal Cord; Uveitis | 2003 |